Osama R. Mawlawi, Ph.D., FAAPM, FACR
Department of Imaging Physics, Division of Diagnostic Imaging
About Dr. Osama R. Mawlawi
Dr. Mawlawi is a Tenured Professor of Imaging Physics and the Section Chief of Nuclear Medicine Physics at the University of Texas MD Anderson Cancer Center. He started his Medical Physics career at Memorial Sloan Kettering Cancer Center in New York as a research assistant from 1990-1998. He later joined Columbia University School of Physicians and Surgeons as an Assistant Professor from 1998-2001 before coming to MDACC in 2001. Dr. Mawlawi has extensive expertise in PET imaging of biomarkers in preclinical applications and in Phase I-III clinical trials. His primary interest focuses on investigating factors affecting absolute quantification of PET/CT images. His ongoing research is aimed at developing novel techniques for PET/CT image acquisition, correction and reformation, as well as modeling the distribution of novel radiotracers. He has authored over 100 peer reviewed articles and book chapters and is the recipient of several grants from industry and professional societies. Dr. Mawlawi is also an active member of several professional societies such as the SNMMI, AAPM, IEEE, RSNA and ACR where he serves in various roles such as task group chair, board member, or review committee and is the past president of the American Board of Science in Nuclear Medicine (ABSNM). Dr. Mawlawi also serves on multiple institutional committees such as the IRG, CRC, RSC, and ECFS. He has won numerous awards, most recently the MD Anderson's President's Recognition for Faculty Excellence Award in 2014. Dr. Mawlawi is frequently invited as a presenter at national and international conferences. He is board certified in Nuclear Medicine Physics and instrumentation by the ABSNM and in Diagnostic Radiologic Physics by the ABR.
Read More
Present Title & Affiliation
Primary Appointment
Section Chief, Nuclear Medicine Physics Section, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Faculty, Graduate School of Biomedical Sciences, Houston, TX
Research Interests
His research interests are focused on Nuclear Medicine physics with specific focus on PET/CT imaging.
Areas of specialization include:
PET/CT and PET/MR image formation, quantification and accuracy | Radionuclide dosimetry | Kinetic modeling
The research in his laboratory is directed at functional imaging using Positron Emission Tomography (PET). A strong interest lies in the factors affecting absolute quantification of PET images such as partial volume, scatter, and patient motion artifacts. Ongoing research is looking at novel techniques of image acquisition, correction and formation. Other interests lie in modeling the distribution of novel radiotracers to image specific biochemical processes such as metabolism, blood flow, receptor binding and expression.
A tutorial in his lab would provide the student with an in-depth experience of functional imaging using PET. Moreover, the student will get hands-on experience with image acquisition, reconstruction, and analysis software tools.
Clinical Interests
PET/CT, SPECT/CT, and Nuclear Medicine imaging | Quality control, assurance, and improvement of Nuclear Medicine and PET imaging
Education & Training
Degree-Granting Education
| 1999 | Columbia University, New York, New York, US, Biomedical Engineering, Ph.D |
| 1990 | Polytechnic University, Brooklyn, New York, US, Biomedical Engineering, M.S |
| 1988 | American University of Beirut, Beirut, LB, Electrical Engineering, BE |
Board Certifications
| 2009 | American Board of Radiology Diagnostic Radiological Physics |
| 2003 | American Board of Science in Nuclear Medicine (ABSNM) |
Experience & Service
Administrative Appointments/Responsibilities
Deputy Department Chair, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present
Past Chair, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019
Chair, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2018
Chair-Elect, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2017
Director, Physician Scientist Advanced Scholar Program, Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present
Section Chief, Nuclear Medicine Physics Section, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Mentoring Program Coordinator, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2018
Imaging Physics Research Committee Member, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - Present
Nuclear Medicine Research Peer Review Committee, Department of Imaging Physics - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - Present
Imaging Physics Residency Program Steering Committee, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - Present
Medical Physics Graduate Program Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2013
Other Appointments/Responsibilities
Past President, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Physics Instrumentation and Data Science (PIDS) Council, Reston, VA, 2021 - 2022
President, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Physics Instrumentation and Data Science (PIDS) Council, Reston, VA, 2020 - 2021
Chair, American College of Radiology, Nuclear Medicine Physics Accreditation Subcommittee, Reston, VA, 2020 - 2024
President Elect, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Physics Instrumentation and Data Science (PIDS) Council, Reston, VA, 2019 - 2020
Past President, Board of Directors, American Board of Science in Nuclear Medicine, Reston, VA, 2013 - 2015
President, Board of Directors, American Board of Science in Nuclear Medicine, Reston, VA, 2011 - 2013
Treasurer, Society of Nuclear Medicine, Computer and Instrumentation Council, Reston, VA, 2010 - 2012
President Elect, Board of Directors, American Board of Science in Nuclear Medicine, Reston, VA, 2010 - 2011
Member, Board of Directors, American Board of Science in Nuclear Medicine, Reston, VA, 2009 - Present
Consultant, International Atomic Energy Agency (IAEA), Houston, TX, 2008 - 2020
Consultant, American College of Radiology (ACR), Reston, Virginia, 2006 - Present
Contract consultant, Amgen Inc, Thousand Oaks, CA, 2006 - 2009
Institutional Committee Activities
Member, Institutional Conflict of Interest, 2024 - Present
Member, Search Committee Member for Chair of the Department of Abdominal Imaging, Division of Diagnostic Imaging, 2022
Search Committee Member for Director, Center for Professionalism Standards and Support, 2021
Search Committee Member for Division Head of Anesthesiology, Critical Care & Pain Medicine, 2021
Search Committee Member for Director, Faculty and Academic Wellness, 2021
Parliamentarian, Faculty Senate Executive Committee, 2019 - 2022
Member, Strategic Planning Committee, 2018 - Present
Chair, Chair of Search Committee for the Division of Radiation Oncology, 2018 - 2019
Member, Search Committee Member for Chief Academic Officer of MD Anderson Cancer Center, 2018
Member, Search Committee Member for Chair of Radiation Physics, MD Anderson Cancer Center, 2018
Co-Chair, Search Committee Member for Vice Chair of Research in Diagnostic Radiology, 2018
Member, Institutional Conflict of Interest Committee, MD Anderson Cancer Center, 2018 - 2019
Member, Search Committee for Director of PET/MR in Division of Diagnostic Imaging, 2017
Member, Technology Task Force, Division of Diagnostic Imaging, 2017 - Present
Member, Search Committee for President of MD Anderson Cancer Center, 2017
Co-Chair, Search Committee for Section Chief of Abdominal Imaging in Diagnostic Radiology, 2017
Member, Faculty Research Committee, Division of Diagnostic Imaging, 2016 - Present
Member, Faculty Education Committee, Division of Diagnostic Imaging, 2016 - Present
Co-Chair, Faculty Functional Committee, Division of Diagnostic Imaging, 2016 - Present
Member, Faculty Functional Committee, Division of Diagnostic Imaging, 2014 - 2016
Member, Executive Committee of the Faculty Senate (ECSF), 2013 - 2022
Member, Faculty Mentoring Advisory Committee, 2013 - Present
Member, Radiation Safety Committee, 2012 - Present
Imaging Physics Representative, Faculty Senate, 2012 - 2019
Member, Study Section Review Committee for Clinical Translational and Population-Based Research Projects; Institutional Research Grants Program, 2011 - 2014
Member, Credentials Committee of the Medical Staff, 2009 - 2011
Member, Study section review committee for Basic Research Projects; Institutional Research Grants Program, 2008 - 2011
Member, Clinical Research Committee (CRC), 2006 - 2009
Member, PET/CT Strategic Planning Committee, 2003 - 2008
Member, PACS Steering Committee, 2003 - 2008
Honors & Awards
| 2024 | Diagnostic Imaging Citizenship Award, The University of Texas MD Anderson Cancer Center |
| 2018 | Fellow, American College of Radiology |
| 2017 | President’s Recognition for Faculty Excellence - Excellence in Financial Stewardship, The University of Texas MD Anderson Cancer Center |
| 2014 | President’s Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center |
| 2013 | Fellow, American Association of Physicist in Medicine |
| 2011 | Re-Award of Tenure, The University of Texas MD Anderson Cancer Center |
| 2005 | Tenure, The University of Texas MD Anderson Cancer Center |
| 2005 | Outstanding Contributions to JNMT, Society of Nuclear Medicine |
| 1997 | Scientific Exhibits Section of the Society of Nuclear Medicine, Society of Nuclear Medicine |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Parker, S, Weygand, J, Bernat, BG, Jackson, AM, Mawlawi, O, Barreto, I, Hao, Y, Khan, R, Yorke, AA, Swanson, W, Huq, MS, Lief, E, Biancia, CD, Njeh, CF, Al-Basheer, A, Chau, OW, Avery, S, Ngwa, W, Sandwall, PA. Assessing Radiology and Radiation Therapy Needs for Cancer Care in Low-and-Middle-Income Countries. Advances in Radiation Oncology 9(11), 2024. e-Pub 2024. PMID: 39410956.
- Parker SA, Weygand J, Bernat BG, Jackson AM, Mawlawi O, Barreto I, Hao Y, Khan R, Yorke AA, Swanson W, Huq MS, Lief E, Biancia CD, Njeh CF, Al-Basheer A, Chau OW, Avery S, Ngwa W, Sandwall PA. Assessing Radiology and Radiation Therapy Needs for Cancer Care in Low-and-Middle-Income Countries: Insight From a Global Survey of Departmental and Institutional Leaders. Adv Radiat Oncol 9(11):101615, 2024. e-Pub 2024. PMID: 39410956.
- Fraum TJ, Sari H, Dias AH, Munk OL, Pyka T, Smith AM, Mawlawi OR, Laforest R, Wang G. Whole-Body Multiparametric PET in Clinical Oncology: Current Status, Challenges, and Opportunities. AJR Am J Roentgenol 223(5), 2024. e-Pub 2024. PMID: 39230403.
- AlMazrou RY, Alanazi SF, Alzaid MH, Al-Fakhranee RS, Ding S, Mawlawi OR. Performance characteristics of the 5-ring GE Discovery MI PET/CT scanner using AAPM TG-126 report. J Appl Clin Med Phys 25(4):e14315, 2024. e-Pub 2024. PMID: 38415897.
- Abouzahr F, Cesar JP, Crespo P, Gajda M, Hu Z, Klein K, Kuo AS, Majewski S, Mawlawi, O, Morozov A, Ojha A, Poenisch F, Proga M, Sahoo N, Seco J, Takaoka T, Tavernier S, Titt U, Wang X, Zhu XR, Lang K. The first probe of a FLASH proton beam by PET. Phys Med Biol 68(23), 2023. e-Pub 2023. PMID: 37918021.
- Ravizzini G, Erwin W, De Palatis L, Martiniova L, Subbiah V, Paolillo V, Mitchell J, McCoy AP, Gonzalez J, Mawlawi, O. Dosimetry of a Novel 111Indium-Labeled Anti-P-Cadherin Monoclonal Antibody (FF-21101) in Non-Human Primates. Cancers (Basel) 15(18), 2023. e-Pub 2023. PMID: 37760501.
- Abouzahr F, Cesar JP, Crespo P, Gajda MJ, Hu Z, Kaye W, Klein K, Kuo A, Majewski S, Mawlawi, O, Morozov A, Ojha A, Poenisch F, Polf JC, Proga M, Sahoo N, Seco J, Takaoka T, Tavernier S, Titt U, Wang X, Zhu XR, Lang K. The first PET glimpse of a proton FLASH beam. Phys Med Biol. e-Pub 2023. PMID: 37141903.
- Nguyen TDT, Wang Y, Bui TN, Lazcano R, Ingram DR, Yi M, Vakulabharanam V, Luo L, Pina MA, Karakas C, Li M, Kettner NM, Somaiah N, Hougton PJ, Mawlawi, O, Lazar AJ, Hunt KK, Keyomarsi K. Sequential targeting of retinoblastoma and DNA synthesis pathways is a therapeutic strategy for sarcomas that can be monitored in real-time. Cancer Res 83(6):939-955, 2023. e-Pub 2023. PMID: 36603130.
- Meier JG, Diab RH, Connor TM, Mawlawi, O. Impact of low injected activity on data driven respiratory gating for PET/CT imaging with continuous bed motion. J Appl Clin Med Phys 23(5):e13619, 2022. e-Pub 2022. PMID: 35481961.
- Catana C, Laforest R, An H, Boada F, Cao T, Faul D, Jakoby B, Jansen FP, Kemp BJ, Kinahan PE, Larson P, Levine MA, Maniawski P, Mawlawi, O, McConathy JE, McMillan AB, Price JC, Rajagopal A, Sunderland J, Veit-Haibach P, Wangerin KA, Ying C, Hope TA. A Path to Qualification of PET/MR Scanners for Multicenter Brain Imaging Studies: Evaluation of MR-based Attenuation Correction Methods Using a Patient Phantom. J Nucl Med 63(4):615-621, 2022. e-Pub 2022. PMID: 34301784.
- Thomas MA, Meier JG, Mawlawi, O, Sun P, Pan T. Impact of acquisition time and misregistration with CT on data-driven gated PET. Phys Med Biol 67(8):10, 2022. e-Pub 2022. PMID: 35313286.
- Seyedin SN, Bassalow R, Mawlawi, O, Turner LM, Patel RR, Mazin SR, Oderinde OM, Voronenko Y, Wages CA, Olcott PD, Chang JY, Balter PA, Welsh JW. The potential of biology-guided radiation therapy in thoracic cancer: A preliminary treatment planning study. Front Oncol 12:921473, 2022. e-Pub 2022. PMID: 36313653.
- Wallis JW, Klein R, Bradshaw TJ, Catana C, Hatt M, Laforest R, Liu C, Mawlawi, O, McCall KC, Osborne DR, Tang J, Wells RG, Ghesani M. Guidelines on Setting Up Stations for Remote Viewing of Nuclear Medicine and Molecular Imaging Studies During COVID-19.. J Nucl Med Technol 49(1):2-6, 2021. e-Pub 2021. PMID: 33380520.
- Lopez BP, Jordan DW, Kemp BJ, Kinahan PE, Schmidtlein CR, Mawlawi OR. PET/CT acceptance testing and quality assurance: Executive summary of AAPM Task Group 126 Report. Med Phys 48(2):e31-e35, 2021. e-Pub 2021. PMID: 33320364.
- Johnson JM, Chen MM, Rohren EM, Prabhu S, Chasen B, Mawlawi, O, Liu HL, Gule-Monroe MK. Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing. Front Neurol 12:740280, 2021. e-Pub 2021. PMID: 34867723.
- Subbiah V, Erwin W, Mawlawi, O, McCoy A, Wages D, Wheeler C, Gonzalez-Lepera C, Liu H, Macapinlac H, Meric-Bernstam F, Hong DS, Pant S, Le D, Santos E, Gonzalez J, Roszik J, Suzuki T, Subach RA, Madden T, Johansen M, Nomura F, Satoh H, Matsuura T, Kajita M, Nakamura E, Funase Y, Matsushima S, Ravizzini G. Phase I Study of P-cadherin-targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors. Clin Cancer Res 26(22):5830-5842, 2020. e-Pub 2020. PMID: 32816889.
- Beyer T, Bidaut L, Dickson J, Kachelriess M, Kiessling F, Leitgeb R, Ma J, Shiyam Sundar LK, Theek B, Mawlawi, O. What scans we will read: imaging instrumentation trends in clinical oncology. Cancer Imaging 20(1):38, 2020. e-Pub 2020. PMID: 32517801.
- Wong TZ, Benefield T, Masters SC, Kiser JW, Crowley JR, Osborne D, Mawlawi, O, Barnwell J, Gupta P, Mintz A, Ryan KA, Perrin SR, Lattanze RK, Townsend DW. Findings from Quality Improvement Initiatives to Assess and Improve PET/CT FDG Injection Infiltration Rates in Multiple Centers. J Nucl Med Technol. e-Pub 2019. PMID: 31182666.
- Zhou M, Chen Y, Adachi M, Wen X, Erwin B, Mawlawi, O, Lai SY, Li C. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Biomaterials 57:41-49. e-Pub 2015. PMID: 25913249.
Selected Presentations & Talks
Local Presentations
- 2024. QC of Novel Imaging Devices & Equipment. IAEA Interregional Training Course on Train-the-Trainer on QUANUM and the Patient Journey Audit Tool. Invited. QC of Novel Imaging Devices & Equipment. Houston, Texas, US.
- 2012. Nuclear Medicine Breast Imaging. Conference. Nuclear Medicine Breast Imaging. Houston, TX, US.
- 2011. Sources and remedies of variability in PET SUV measurements. Conference. Sources and remedies of variability in PET SUV measurements. Houston, TX, US.
- 2010. Factors affecting quantification in PET and PET/CT imaging. Conference. Factors affecting quantification in PET and PET/CT imaging. Houston, TX, US.
- 2004. PET/CT: the hows and whys behind this imaging modality. Conference. PET/CT: the hows and whys behind this imaging modality. Houston, TX, US.
National Presentations
- 2025. PET II: Quality Assurance, Testing and Quantification. Conference. Advanced Course on Biomedical Imaging, PT.
- 2025. Challenges and potential solutions to clinical trials - a physicist perspective. Invited. Virtual, US.
- 2024. Technical Update: Recent Innovations in Thoracic PET-CT. Conference. Radiological Society of North America (RSNA) 110th Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2024. Radiation Dose Comparison: PET/CT vs PET/MR. Conference. Radiological Society of North America (RSNA) 110th Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2024. PET fundamental principles. Conference. Nuclear medicine review course. Washington, DC, US.
- 2024. PET I: Basics. Conference. Advanced Course on Biomedical Imaging, PT.
- 2024. Advances in PET/CT Imaging. Conference. Advanced Course on Biomedical Imaging, PT.
- 2023. What is new in Nuclear Medicine from NM physicist perspective. Conference. What is new in Nuclear Medicine from NM physicist perspective. Chicago, IL, US.
- 2023. Advances and Quantification in PET/CT. Conference. Advances and Quantification in PET/CT. Houston, TX, US.
- 2023. PET fundamental principles. Conference. Nuclear medicine review course. Washington, DC, US.
- 2023. Quadra PET/CT. Conference. Quadra PET/CT. Chicago, IL, US.
- 2022. Digital PET in Current Radiology Practice: State of the Art PET Technology from GE. Conference. Digital PET in Current Radiology Practice: State of the Art PET Technology from GE. Chicago, IL, US.
- 2022. PET fundamental principles. Conference. Nuclear medicine review course. Washington, DC, US.
- 2022. ACR Updates Including the New Stereotactic Breast Biopsy QC Manual. Conference. ACR Updates Including the New Stereotactic Breast Biopsy QC Manual. Washington, DC, DC, US.
- 2022. Medical Physics Cross-Specialization in the Era of Radiotheranostics. Conference. Medical Physics Cross-Specialization in the Era of Radiotheranostics. Washington, DC, DC, US.
- 2022. Quantification in PET/CT Imaging. Conference. Quantification in PET/CT Imaging. San Antonio, TX, US.
- 2021. Digital PET in Current Radiology Practice: State of the Art PET technology from GE. Conference. Digital PET in Current Radiology Practice: State of the Art PET technology from GE. Chicago, IL, US.
- 2021. Advances and Quantification in PET/CT. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2021. PET fundamental principles. Conference. American Association of Physicist in Medicine (AAPM). Washington, DC, US.
- 2021. PET/CT Acceptance Testing and Quality Assurance: AAPM TG126. Conference. PET/CT Acceptance Testing and Quality Assurance: AAPM TG126, US.
- 2020. ACR Update in Nuclear Medicine “Physics” Accreditation. Conference. ACR Update in Nuclear Medicine “Physics” Accreditation, US.
- 2020. Innovations in Hybrid Imaging: Recent Advances in PET Imaging. Conference. Innovations in Hybrid Imaging: Recent Advances in PET Imaging, US.
- 2020. Academic, Clinical and Industrial Pathways for Nuclear Medicine Physicists, Engineers and Data Scientists Webinar. Conference. Academic, Clinical and Industrial Pathways for Nuclear Medicine Physicists, Engineers and Data Scientists Webinar, US.
- 2020. Technological Developments and Fundamentals of Quantitative PET. Conference. Technological Developments and Fundamentals of Quantitative PET, FL, US.
- 2020. Quality Control Acceptance Testing and Quantitative Imaging. Conference. Quality Control Acceptance Testing and Quantitative Imaging, FL, US.
- 2019. Innovations in PET/CT. Conference. Innovations in PET/CT. Chicago, US.
- 2019. Technological Advances in PET Imaging. Conference. Technological Advances in PET Imaging. Anaheim, CA, US.
- 2019. Recent Advances in PET Imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2019. Theoretical Aspects of PET/CT. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. PET/CT Introduction and Clinical Applications. Conference. PET/CT Introduction and Clinical Applications. Chicago, IL, US.
- 2018. Update on PET Testing TG126 – Physics Testing of Gamma Cameras and PET Scanners: Reports from TG 177 and TG126. Conference. Update on PET Testing TG126 – Physics Testing of Gamma Cameras and PET Scanners: Reports from TG 177 and TG126. Nashville, TN, US.
- 2018. Solid Slate Photo Detection PET Instrumentation and Technology – Discovery MI PET/CT and Signa PET/MR. Conference. Solid Slate Photo Detection PET Instrumentation and Technology – Discovery MI PET/CT and Signa PET/MR. Nashville, TN, US.
- 2018. Advances in PET Imaging. Conference. Advances in PET Imaging. Winston-Salem, NC, US.
- 2018. Quantification Challenges in PET/CT Imaging. Conference. Quantification Challenges in PET/CT Imaging. Winston-Salem, NC, US.
- 2018. PET/CT Instrumentation. Conference. PET/CT Instrumentation. Houston, TX, US.
- 2018. Advances and Quantification in PET/CT Imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Basic Principles of PET Imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Advances in NM/PET Imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2017. New Generation Solid State LightBurst PET. Conference. New Generation Solid State LightBurst PET. Denver, CO, US.
- 2017. Board Certification from the ABR. Conference. Board Certification from the ABR. Denver, CO, US.
- 2017. Solid State LightBurst New PET Technology - GE PET/CT and PET/MR. Conference. Solid State LightBurst New PET Technology - GE PET/CT and PET/MR. Denver, CO, US.
- 2017. Team Based Nuclear Medicine: Best Practices. Conference. Team Based Nuclear Medicine: Best Practices. Denver, CO, US.
- 2016. Advances and Quantification in PET/CT. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2016. AAPM/RSNA Basic Physics Lecture for the RT: Hybrid Imaging: Past, Present and Future. Conference. AAPM/RSNA Basic Physics Lecture for the RT: Hybrid Imaging: Past, Present and Future. Chicago, IL, US.
- 2015. Nuclear Imaging 1.0. Conference. Nuclear Imaging 1.0. Chicago, IL, US.
- 2015. Uncertainty in PET Image Quantification. Conference. Uncertainty in PET Image Quantification. Baltimore, MD, US.
- 2015. PET Performance Measurements. Conference. PET Performance Measurements. Baltimore, MD, US.
- 2014. Nuclear Imaging 1.0. Conference. Nuclear Imaging 1.0. Chicago, IL, US.
- 2014. Web-based Nuclear Medicine Quality Assurance Tool. Conference. Web-based Nuclear Medicine Quality Assurance Tool. Chicago, IL, US.
- 2014. Hybrid Imaging in Nuclear Medicine. Conference. Hybrid Imaging in Nuclear Medicine. Chicago, IL, US.
- 2014. Thoracic PET-CT: Quantification and interpretation challenges. Conference. Thoracic PET-CT: Quantification and interpretation challenges. San Diego, CA, US.
- 2014. Refresher and What's New in PET/Gamma Camera Cardiac Imaging. Conference. Refresher and What's New in PET/Gamma Camera Cardiac Imaging. Denver, CO, US.
- 2012. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Conference. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Chicago, IL, US.
- 2012. PET/CT QA/QC and Acceptance Testing. Conference. PET/CT QA/QC and Acceptance Testing. Charlotte, NC, US.
- 2012. Acceptance testing and QC programs including artifacts and troubleshooting. Conference. Acceptance testing and QC programs including artifacts and troubleshooting. San Diego, CA, US.
- 2012. PET/MR: Status update and Opportunities. Conference. PET/MR: Status update and Opportunities. Oklahoma City, OK, US.
- 2011. New era of radiotherapy: An update in radiation-induced lung disease. Conference. New era of radiotherapy: An update in radiation-induced lung disease. Chicago, IL, US.
- 2011. PET Qualification and artifacts. Conference. PET Qualification and artifacts. Chicago, IL, US.
- 2011. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Conference. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Chicago, IL, US.
- 2011. Thoracic PET-CT: Quantification and Interpretation Predicaments. Conference. Thoracic PET-CT: Quantification and Interpretation Predicaments. Chicago, IL, US.
- 2010. SPECT/CT and PET/CT installation and testing: Acceptance and QC. Conference. SPECT/CT and PET/CT installation and testing: Acceptance and QC. Chicago, IL, US.
- 2010. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Conference. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Chicago, IL, US.
- 2010. PET/CT: Technology updates, Quality assurance and Applications. Conference. PET/CT: Technology updates, Quality assurance and Applications. Philadelphia, PA, US.
- 2010. The actions we take: The truth about Iodinated Contrast. PET Center of Excellence. Conference. The actions we take: The truth about Iodinated Contrast. PET Center of Excellence. Salt Lake City, UT, US.
- 2010. Physics Perspectives on PET Imaging. Conference. Physics Perspectives on PET Imaging. San Antonio, TX, US.
- 2010. Thoracic PET-CT: Interpretation predicaments and Future Development. Conference. Thoracic PET-CT: Interpretation predicaments and Future Development. San Diego, CA, US.
- 2009. Quantitative Accuracy in PET Imaging. Conference. Quantitative Accuracy in PET Imaging. Chicago, IL, US.
- 2009. Educational Exhibit, Physics case of the day. Conference. Educational Exhibit, Physics case of the day. Chicago, IL, US.
- 2009. PET/CT Technology Update, Quality Assurance and applications. Conference. American Association of Physics in Medicine. Anaheim, CA, US.
- 2009. Quantification in PET/CT Imaging. Conference. Quantification in PET/CT Imaging. Boston, MA, US.
- 2009. Positron Emission Mammography. Conference. Positron Emission Mammography. San Antonio, TX, US.
- 2008. PET/CT Imaging and Factors Affecting SUV Measurements, The future of Quantitative and functional lung imaging. Conference. PET/CT Imaging and Factors Affecting SUV Measurements, The future of Quantitative and functional lung imaging. Coralville, IA, US.
- 2008. PET/CT: Technology Updates, Quality Assurance and Applications. Conference. AAPM Annual Meeting. Houston, TX, US.
- 2008. Factors affecting SUV and Quantification. Conference. American Association of Physicists in Medicine Summer School meeting 2008. Houston, TX, US.
- 2008. PET ACR Accreditation and Acceptance Testing. Conference. American Association of Physicists in Medicine Summer School meeting 2008. Houston, TX, US.
- 2008. Nuclear Medicine Today and Tomorrow: Integrating SPECT/CT for Whole Body Imaging. Conference. Society of Nuclear Medicine Annual Meeting. New Orleans, LA, US.
- 2008. Factors Affecting SUV Quantification in PET/CT Imaging. Conference. American Roentgen Ray Society (ARRS) annual meeting. Washington, DC, US.
- 2007. Educational Exhibit, Physics case of the day. Conference. Educational Exhibit, Physics case of the day. Chicago, IL, US.
- 2007. PET Dosimetry and Factors Affecting Image Quantification. Conference. Annual meeting of the Council on Ionizing Radiation Measurements and Standards. Gaithersbury, MD, US.
- 2007. PET accreditation and Quality Assurance. Conference. AAPM Annual Meeting. Minneapolis, MN, US.
- 2007. PET CT Workshop: PET/CT Scanner Offering from Different Manufacturers. Conference. PET CT Workshop: PET/CT Scanner Offering from Different Manufacturers. Minneapolis, MN, US.
- 2007. PET/CT instrumentation update and review. Conference. Society of Nuclear Medicine Annual Meeting. Washington, DC, US.
- 2007. QA and QC in quantitative PET/CT imaging. Conference. Society of Nuclear Medicine Annual Meeting. Washington, DC, US.
- 2006. PET/CT Instrumentation: What's available and how it works - GE PET/CT systems. Conference. Society of Nuclear Medicine Annual Meeting. San Diego, CA, US.
- 2006. NCI Workshop: Use of PET CT in the Clinic and Clinical Trials: Quantitation for Change Analysis - Quality Assurance for Quantitative PET/CT. Conference. Society of Nuclear Medicine Annual Meeting. Washington, DC, US.
- 2006. Quantitative techniques in PET, Academy of Molecular Imaging Annual Meeting. Conference. Quantitative techniques in PET, Academy of Molecular Imaging Annual Meeting. Orlando, FL, US.
- 2006. PET and PET/CT instrumentation. Conference. Academy of Molecular Imaging Annual. Orlando, FL, US.
- 2005. 4D PET/CT: Instrumentation, image acquisition, and application to radiation therapy planning. Conference. Academy of Molecular Imaging Annual Meeting. Orlando, FL, US.
- 2004. From PET to MicroPET Imaging. Conference. 12th Annual Radiation Workshop. Round Top, TX, US.
- 2004. Emerging trends in PET/CT imaging. Conference. Academy of Molecular Imaging Annual Meeting. Orlando, FL, US.
- 2002. Positron Emission Tomography: Trends and Performance Standards. Conference. South Western Chapter American Association of Physicists in Medicine Annual Meeting. Dallas, TX, US.
- 2002. So You're Putting in a PET Scanner. Conference. South Western Chapter Society of Nuclear Medicine 47th Annual Meeting. Galveston, TX, US.
- 2001. PET Mini Fellowship 2001. Conference. Columbia University College of Physicians and Surgeons, Department of Radiology. New York, NY, US.
- 1997. Multimodality Brain Image Registration using a 3:D Photogrammetrically Derived Surface. Conference. Multimodality Brain Image Registration using a 3:D Photogrammetrically Derived Surface. San Antonio, TX, US.
International Presentations
- 2025. Challenges and potential solutions to clinical trials – a physicist perspective. Invited. Virtual, US.
- 2023. What is new in Nuclear Medicine from NM physicist perspective. Conference. What is new in Nuclear Medicine from NM physicist perspective, SA.
- 2023. Recent advances in PET/CT & SPECT/CT. Conference. Recent advances in PET/CT & SPECT/CT. Skopje, MK.
- 2023. PET I: Basics, Advanced Course on Biomedical Imaging. Conference. PET I: Basics, Advanced Course on Biomedical Imaging, PT.
- 2023. Medical physics cross specialization in the era of radiotheranostics. Conference. Medical physics cross specialization in the era of radiotheranostics. Muscat, OM.
- 2023. PET II: Quality Assurance, Testing and Quantification, Advanced Course on Biomedical Imaging. Conference. PET II: Quality Assurance, Testing and Quantification, Advanced Course on Biomedical Imaging, PT.
- 2023. Advances in PET/CT Imaging, Advanced Course on Biomedical Imaging. Conference. Advances in PET/CT Imaging, Advanced Course on Biomedical Imaging, PT.
- 2023. PET acceptance testing and quality assurance: AAPM Task Group 126 Report. Conference. PET acceptance testing and quality assurance: AAPM Task Group 126 Report. Muscat, OM.
- 2022. QA/QC in PET and SPECT Imaging. Conference. QA/QC in PET and SPECT Imaging, MA.
- 2022. Quantification Challenges in PET/CT. Conference. Quantification Challenges in PET/CT, MA.
- 2022. Recent Advances in PET/CT Imaging. Conference. Recent Advances in PET/CT Imaging, MA.
- 2022. PET II: Quality Assurance, Testing and Quantification. Conference. PET II: Quality Assurance, Testing and Quantification, PT.
- 2022. Advances in PET/CT Imaging. Conference. Advances in PET/CT Imaging, PT.
- 2022. PET I: Basics. Conference. PET I: Basics, PT.
- 2022. Recent Advances in PET/CT. Conference. Recent Advances in PET/CT, SA.
- 2022. PET Parameters Standardization; SUV, MTV and TLG. Conference. PET Parameters Standardization; SUV, MTV and TLG, SA.
- 2022. Acceptance Testing of PET Using AAPM TG-126. Conference. Acceptance Testing of PET Using AAPM TG-126, SA.
- 2022. Image Reconstruction Algorithms and Image Optimizing in PET/CT. Conference. Image Reconstruction Algorithms and Image Optimizing in PET/CT, SA.
- 2021. Recent Advances in PET/CT and PET/MR Designs. Conference. Recent Advances in PET/CT and PET/MR Designs, KW.
- 2021. Advances in PET Imaging. Conference. Advances in PET Imaging, IN.
- 2020. Image Reconstruction Algorithms and Image Optimizing in PET/CT. Conference. Image Reconstruction Algorithms and Image Optimizing in PET/CT, SA.
- 2020. Quantification in PET-CT Imaging. Conference. Quantification in PET-CT Imaging, SA.
- 2020. Digital PET Scanner. Conference. Digital PET Scanner, SA.
- 2020. State of the Art and Future Perspectives in PET Imaging. Conference. State of the Art and Future Perspectives in PET Imaging, SA.
- 2019. Fundamentals of SPECT & SPECT-CT. Conference. International Symposium on Medical Imaging Physics & Image Guidance in Radiotherapy, IN.
- 2019. Fundamentals of PET & PET-CT. Conference. International Symposium on Medical Imaging Physics & Image Guidance in Radiotherapy, IN.
- 2019. Advances in PET, SPECT and QA/QC in PET and SPECT. Conference. International Symposium on Medical Imaging Physics & Image Guidance in Radiotherapy, IN.
- 2019. PET/CT QC. Conference. PET/CT QC, SA.
- 2019. PET SUV and the Future of Digital PET. Conference. PET SUV and the Future of Digital PET. Ottawa, CA.
- 2017. Advances in PET and SPECT (Including PET/MR). Conference. Advances in PET and SPECT (Including PET/MR), PE.
- 2017. Basic Gamma Camera/SPECT and QC Physics. Conference. Basic Gamma Camera/SPECT and QC Physics, PE.
- 2017. Basic PET/CT Camera and QC Physics. Conference. Basic PET/CT Camera and QC Physics, PE.
- 2017. Testing/Commissioning of PET and Gamma Camera. Conference. Testing/Commissioning of PET and Gamma Camera, PE.
- 2013. Advantages and Advances in Nuclear hybrid Imaging systems. Conference. Advantages and Advances in Nuclear hybrid Imaging systems. Bangkok, TH.
- 2013. Quantification in Hybrid Modalities. Conference. Quantification in Hybrid Modalities. Bangkok, TH.
- 2013. PET/CT Testing/QA and Dose Reduction Techniques. Conference. PET/CT Testing/QA and Dose Reduction Techniques. Bangkok, TH.
- 2013. Thoracic PET-CT: Quantification and Interpretation Predicaments. Conference. Thoracic PET-CT: Quantification and Interpretation Predicaments. Vancouver, CA.
- 2013. Overview of PET Quantification for Radiopharmaceutical Dosimetry. Conference. Overview of PET Quantification for Radiopharmaceutical Dosimetry. Vancouver, CA.
- 2012. PET/CT, SPECT/CT and gamma camera: Basic Physics and Quality Assurance: Diagnostic Imaging Workshop. Conference. PET/CT, SPECT/CT and gamma camera: Basic Physics and Quality Assurance: Diagnostic Imaging Workshop. Buenos Aires, AR.
- 2012. PET/CT, SPECT/CT and gamma camera: Acceptance and annual testing: Diagnostic Imaging Workshop. Conference. PET/CT, SPECT/CT and gamma camera: Acceptance and annual testing: Diagnostic Imaging Workshop. Buenos Aires, AR.
- 2012. PET/CT, SPECT/CT and gamma camera: Dosimetry. Diagnostic Imaging workshop. Conference. PET/CT, SPECT/CT and gamma camera: Dosimetry. Diagnostic Imaging workshop. Buenos Aires, AR.
- 2012. PET/CT, SPECT/CT and gamma camera: Emerging technologies in Nuclear Medicine Diagnostic Imaging workshop. Conference. PET/CT, SPECT/CT and gamma camera: Emerging technologies in Nuclear Medicine Diagnostic Imaging workshop. Buenos Aires, AR.
- 2012. Thoracic PET-CT: Quantification and Interpretation Predicaments. Conference. Thoracic PET-CT: Quantification and Interpretation Predicaments. Vancouver, CA.
- 2012. Quantification in PET/CT imaging: Barriers and solutions. Conference. Quantification in PET/CT imaging: Barriers and solutions. Riyadh, SA.
- 2012. PET/CT QA/QC and Acceptance Testing. Conference. PET/CT QA/QC and Acceptance Testing. Riyadh, SA.
- 2012. 4D PET/CT imaging and its applications in oncology. Conference. 4D PET/CT imaging and its applications in oncology. Riyadh, SA.
- 2012. Advances in PET imaging. Conference. Advances in PET imaging. Riyadh, SA.
- 2011. Patient dose in CT imaging. Conference. Patient dose in CT imaging. Muscat, OM.
- 2011. CT scanner settings and image quality. Conference. CT scanner settings and image quality. Muscat, OM.
- 2011. PET recent technology updates. Conference. PET recent technology updates. Porto Alegre, BR.
- 2011. Advances in Quantitative PET/CT. Conference. Advances in Quantitative PET/CT. Porto Alegre, BR.
- 2011. PET Accreditation. Conference. PET Accreditation. Porto Alegre, BR.
- 2011. PET acceptance testing. Conference. PET acceptance testing. Porto Alegre, BR.
- 2011. PET QA/QC and TG updates. Conference. PET QA/QC and TG updates. Porto Alegre, BR.
- 2010. Quantification accuracy in Brain PET imaging. Conference. Quantification accuracy in Brain PET imaging, TW.
- 2010. Quantification accuracy in Brain PET imaging. Conference. Quantification accuracy in Brain PET imaging, TW.
- 2009. Techniques for Reducing Motion Artifacts in PET/CT Imaging. Conference. Techniques for Reducing Motion Artifacts in PET/CT Imaging. Hangzhou, CN.
- 2009. Multimodality Equipment Quality Control Issues. Conference. Multimodality Equipment Quality Control Issues. Toronto, CA.
- 2009. Implementation and Optimization of a New Super Resolution Technique in PET Imaging. Conference. Implementation and Optimization of a New Super Resolution Technique in PET Imaging. Boston, US.
- 2009. PET/CT Instrumentation, A Technology Update. Conference. PET/CT Instrumentation, A Technology Update. Toronto, CA.
- 2007. Artifacts and Quantification in PET/CT Imaging. Conference. International symposium on Imaging Science and technology in Drug discovery and development. Sendai, JP.
- 2005. PET/CT: The tried and true and a look at what's new: PET/CT instrumentation. Conference. Society of Nuclear Medicine Annual Meeting. Toronto, CA.
- 2005. PET/CT Instrumentation: What's available and how it works - GE PET/CT systems. Conference. Society of Nuclear Medicine Annual Meeting. Toronto, CA.
Formal Peers
- 2024. Advances in PET/CT Imaging. Portugal (Virtual), PT.
- 2024. PET II: Quality Assurance. Portugal (Virtual), PT.
- 2024. PET I: Basics. Portugal (Virtual), PT.
- 2024. Quadra PET/CT. Houston, Texas, US.
- 2022. Advances in PET Imaging. Invited, GR.
- 2022. Nuclear Medicine Medical Physics Pathway in the USA. Invited, GR.
- 2022. Opportunities in Clinical Support for NM physicists. Invited. Baltimore, MD, US.
- 2018. Advances in PET Imaging. Invited. Winston-Salem, NC, US.
- 2018. Quantification Challenges in PET/CT Imaging. Invited. Winston-Salem, NC, US.
- 2017. Advances in PET imaging: motion correction, proton therapy verification and PET/MR. Invited. New Haven, CT, US.
- 2012. Dose issues in PET and CT imaging of small animals. Invited. Houston, TX, US.
- 2009. Factors affecting PET/CT quantification. Invited. Houston, TX, US.
- 2009. The physics of PET/CT. Invited. Houston, TX, US.
- 2008. Image processing and Visualization techniques applied to cancer imaging: Image Quantification. Invited. Sao Paulo, BR.
- 2007. Clinical Impact of 4D CT and 4D PET/CT in Cancer Diagnosis and Therapy. Invited. Las Vegas, NV, US.
- 2004. 4D PET using LIST mode data acquisition. Invited. Las Vegas, NV, US.
- 2003. The role of PET/CT in radiation oncology. Invited. Houston, TX, US.
Grant & Contract Support
| Date: | 2025 - 2030 |
| Title: | Rationale targeting of the cell cycle to sensitize soft tissue sarcomas to chemotherapy through a biomarker-based approach |
| Funding Source: | NIH |
| Role: | Collaborator |
| Date: | 2024 - 2028 |
| Title: | FLASH beams studies using PET/PGI/SPECT imaging and dosimetry |
| Funding Source: | University of Texas at Austin |
| Role: | Co-I |
| ID: | FP00019695 |
| Date: | 2024 - 2025 |
| Title: | Cell Cycle Biomarkers of Sequential Abemaciclib and Gemcitabine Treatment for Advanced Rb1-positive Soft-Tissue Sarcomas |
| Funding Source: | National Leimyosarcoma Foundation |
| Role: | other |
| Date: | 2023 - 2023 |
| Title: | GPU-Accelerated 3D Monte Carlo SPECT Reconstruction Algorithm for Personalized Radiopharmaceutical Therapy |
| Funding Source: | Voximetry, Inc |
| Role: | PI |
| Date: | 2023 - 2025 |
| Title: | Comprehensive Assessment of Cancer Theranostics Response |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5R44CA2850006-02 |
| Date: | 2023 - 2028 |
| Title: | Quantitative and integrated immunologic and diffusion weighted imaging for predicting response to neoadjuvant chemoradiation in esophageal cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA282344-01 |
| Date: | 2023 - 2026 |
| Title: | Assessing response of esophageal cancer to chemoradiation with quantitative PET/MRI |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP230206 |
| Date: | 2022 - 2027 |
| Title: | Assessing response of esophageal cancer to chemoradiation with quantitative PET/MRI |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA266104-01A1 |
| Date: | 2022 - 2027 |
| Title: | Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology |
| Funding Source: | NIH/NCI |
| Role: | Co-Mentor |
| ID: | 5T32CA196561-08 |
| Date: | 2021 - 2023 |
| Title: | Production and Evaluation of 67Cu- and 212Pb-Labeled PSMA-I&T for Targeted Radioligand Therapy |
| Funding Source: | Department of Energy |
| Role: | Co-PI |
| Date: | 2021 - 2026 |
| Title: | Assessing response of esophageal cancer to chemoradiation with quantitative PET/MRI |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA266104-01 |
| Date: | 2021 - 2026 |
| Title: | Sequential targeted therapy and real time monitoring of treatment response by PET imaging in adult and pediatric soft tissue sarcomas |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA258535-01 |
| Date: | 2021 - 2024 |
| Title: | A novel PARP inhibitor PET tracer for breast cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5R01CA249329-02 |
| Date: | 2020 - 2023 |
| Title: | Serial Imaging of the novel radiotracer [18F] Fluorathanatrace ([18F]FTT) by PET/CT |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA249329-01 |
| Date: | 2020 - 2021 |
| Title: | Imaging Biomarker Review - CARNK TAK - 007 |
| Funding Source: | Takeda |
| Role: | Co-PI |
| Date: | 2020 - 2024 |
| Title: | A Novel PARP inhibitor PET tracer for breast cancer |
| Funding Source: | Department of Defense (DOD) |
| Role: | Collaborator |
| ID: | BC190368P1 |
| Date: | 2020 - 2021 |
| Title: | WS#29 Establish the minimum detectable PET activity concentrations when imaging F-18 and Ga-68 labeled prostate cancer radiotracers with the Sigma PET/MR |
| Funding Source: | GE Healthcare |
| Role: | Collaborator |
| ID: | 00058508 |
| Date: | 2020 - 2022 |
| Title: | A Multicenter, Randomized, Controlled Phase 2 Study: Efficacy and Safety of I-131-1095 Radiotherapy in Combination with Enzalutamide in Metastatic Castration- Resistant Prostate Cancer (mCRPC) patients who are 18F-DCFPyL prostate-specific membrane antigen (PSMA)-avid, chemotherapy naive, and progressed on Abiraterone (ARROW) |
| Funding Source: | Progenics |
| Role: | Collaborator |
| ID: | 2019-0364 |
| Date: | 2020 - 2023 |
| Title: | A novel PARP inhibitor PET tracer for breast cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2020 - 2024 |
| Title: | Imaging PARP1 activity using a novel PET tracer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP200375 |
| Date: | 2019 - 2027 |
| Title: | A Multicenter, Randomized, Controlled Phase 2 Study: Efficacy and Safety of I-131-1095 Radiotherapy in Combination with Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients Who Are 18F-Dcfpyl Prostate-Specific Membrane Antigen (ARROW) |
| Funding Source: | Progenics |
| Role: | Collaborator |
| ID: | 2019-0364 |
| Date: | 2019 - 2020 |
| Title: | Data Driven gating (DDG) for PET Imaging |
| Funding Source: | Siemens |
| Role: | PI |
| ID: | PA18-0247 |
| Date: | 2019 - 2022 |
| Title: | [18F]FAZA PET/CT for Monitoring Target Engagement of a Novel Complex I Inhibitor |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5R01CA231506-02 |
| Date: | 2019 - 2021 |
| Title: | Simultaneous PET/MR for enhanced detection of brain lesions using FDG and fMRI |
| Funding Source: | NIH/NIBIB |
| Role: | Co-I |
| ID: | 1R21EB028314-01 |
| Date: | 2019 - 2022 |
| Title: | Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases after Radiation Therapy Metastases After Radiation Therapy |
| Funding Source: | Blue Earth Diagnostics, Ltd |
| Role: | Co-I |
| ID: | 58728 |
| Date: | 2019 - 2020 |
| Title: | An international multi-center, open-label study to evaluate safety, tolerability, biodistribution, dosimetry and preliminary efficacy of 177Lu-OPS201 for the therapy of somatostatin receptorpositive neuroendocrine tumors (NETs) |
| Funding Source: | IPSEN PHARMA SAS |
| Role: | Co-I |
| ID: | 2018-0818 |
| Date: | 2019 - 2022 |
| Title: | Pragmatic Phase II Clinical Trial of Diffusion-Weighted Imaging for Head and Neck Cancer Therapy Response Prediction and Surveillance in comparison to PET/CT |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA227199-01A1 |
| Date: | 2019 - 2020 |
| Title: | Rhesus Lynch Syndrome Project - CABI Pilot Project Program |
| Funding Source: | Internal Funding |
| Role: | Co-I |
| Date: | 2019 - 2022 |
| Title: | [F-18]FAZA PET for Monitoring Targeted Mitochondrial Complex I Inhibition in Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP190270 |
| Date: | 2019 - 2022 |
| Title: | Imaging PARP1 Activity Using a Novel PET Tracer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP190244 |
| Date: | 2019 - 2022 |
| Title: | Sequential targeting of CDK4/6 and DNA synthesis pathways for the treatment of soft tissue sarcomas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| Date: | 2019 - 2020 |
| Title: | An International Multi-Centre, Open-Label Radioactivity Escalation Phase I/IIa Study to Evaluate the Safety, Tolerability, Biodistribution and Preliminary Anti-Tumour Activity of 177Lu-OPS201 for Therapy in Previously Treated Patients |
| Funding Source: | IPSEN PHARMA SAS |
| Role: | Co-I |
| ID: | 2018-0586 |
| Date: | 2018 - 2022 |
| Title: | Imaging of Natural Killer Cell Immunotherapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP180777 |
| Date: | 2018 - 2023 |
| Title: | Standardized Quantitative Imaging Biomarkers for Co-Clinical Trials |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1U24CA220280-01A1 |
| Date: | 2018 - 2021 |
| Title: | Quantitative biophysical parameters from serial tumor images for disease and treatment monitoring |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| Date: | 2018 - 2022 |
| Title: | A Phase II Integrative Study of Image Guided Esophageal Cancer Therapy (INSIGHT) |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP180183 |
| Date: | 2016 - 2018 |
| Title: | Selective Photothermal Ablation of HCC with Renal Clearable [64Cu]CuS Nanodots |
| Funding Source: | GE-Cabi, General Electric |
| Role: | Collaborator |
| Date: | 2016 - 2018 |
| Title: | Renal Clearable Cus Nanodots for Image-Guided Therapy |
| Funding Source: | NIH |
| Role: | Co-I |
| Date: | 2016 - 2019 |
| Title: | Pre-Clinical Development of SUPR Peptides as PET Imaging Agents for Her2-positive Breast Cancer |
| Funding Source: | EvoRx Technologies, Inc |
| Role: | Co-I |
| Date: | 2015 - 2018 |
| Title: | Characterization of Flow Motion Effects on Image Quality and Patient Experience |
| Funding Source: | Siemens |
| Role: | PI |
| ID: | 2015-MI-02-01-Mawlawi-C00219932 |
| Date: | 2015 - 2017 |
| Title: | 4D PET/CT Using HD Chest on Siemens mCT Scanner |
| Funding Source: | Siemens |
| Role: | PI |
| Date: | 2015 - 2018 |
| Title: | Phase 1 Dose-escalation study of Radio-labeled Immunotherapeutic, FF-21101(90Y) for the Treatment of Advanced Cancer |
| Funding Source: | Strategia Therapeutics, Inc |
| Role: | Co-I |
| ID: | 2015-0220-V101 |
| Date: | 2015 - 2019 |
| Title: | Joint HP/MR/PET for Quantitative Measurement of Tumor Metabolism |
| Funding Source: | MDACC/GE Healthcare |
| Role: | Co-PI |
| Date: | 2015 - 2016 |
| Title: | SUPR Peptides for Targeted Radionuclide Delivery |
| Funding Source: | NIH/SBIR with EvoRX |
| Role: | Co-I |
| Date: | 2015 - 2018 |
| Title: | Radiomics approaches to personalized cancer therapy |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 14671 |
| Date: | 2015 - 2018 |
| Title: | An Open-Label Multicenter Phase 1 Study of E7046 |
| Funding Source: | Eisai Inc |
| Role: | Co-I |
| ID: | 2015-0384/ G000 101 |
| Date: | 2015 - 2017 |
| Title: | Dosimetry for Lu-177 DOTATE for Peptide Receptor Radionuclide Therapy (PRRT) for progressive metastatic Neuroendocrine Cancer |
| Funding Source: | RITA Foundation |
| Role: | Principal Investigator-MDACC |
| ID: | 15060849 |
| Date: | 2014 - 2018 |
| Title: | Dosimetry for AminoMedix for Radiation Kidney protection during Peptide-Receptor Radionuclide Therapy (PRRT): Phase I, II Clinical Trial |
| Funding Source: | RadioMedix |
| Role: | PI |
| Date: | 2014 - 2016 |
| Title: | Evaluation of regularized image reconstruction in whole body PET/CT Imaging |
| Funding Source: | MDACC/GE-CABI |
| Role: | Principal Investigator-MDACC |
| ID: | N/A |
| Date: | 2014 - 2017 |
| Title: | Quantitative 90Y PET/CT: Quest Site Assessment Study |
| Funding Source: | SIRTEX Medical Limited |
| Role: | Co-I |
| Date: | 2014 - 2014 |
| Title: | Dosimetry of the novel radiotracer 111ln-FF21101 in non-human primates |
| Funding Source: | Boston Strategies |
| Role: | Co-I |
| Date: | 2013 - 2016 |
| Title: | 4D PET/CT imaging in lung and colorectal cancer with liver metastasis |
| Funding Source: | MDACC/GE-CABIR |
| Role: | Principal Investigator-MDACC |
| ID: | SR2008-00023834EB |
| Date: | 2012 - 2014 |
| Title: | Evaluate the potential and limits of reducing scan time and/or injected activity in multi-gated blood pool (MUGA) imaging using IQ SPECT |
| Funding Source: | SIEMENS Medical Solutions |
| Role: | PI |
| Date: | 2012 - 2017 |
| Title: | Quantitative PET/CT Imaging for Tumor Assessment |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | U01-CA163246-01A |
| Date: | 2011 - 2016 |
| Title: | Quantitative PET/CT Imaging for Tumor Assessment of Esophageal Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | U01-CA163246-01 |
| Date: | 2011 - 2015 |
| Title: | Improving Cord Blood Transplant |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5 P01 CA148600-03 |
| Date: | 2011 - 2016 |
| Title: | DCE/DW-MR and PET/CT imaging biomarkers: Optimization, Translation, and Validation |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| ID: | CA160120-01 |
| Date: | 2010 - 2011 |
| Title: | From Silly and Useless to Sensible and Useful Values in Quantitative PET imaging |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | RO1 CA151377-01 |
| Date: | 2010 - 2012 |
| Title: | Standardization of PET Quantification Across Different Image Acquisition, Processing Parameters and Scanner Platforms |
| Funding Source: | Institutional Research Grant |
| Role: | PI |
| ID: | UTMDACC |
| Date: | 2009 - 2011 |
| Title: | Tracking Peptides across the Blood-Brain Barrier with 18F-Boron Radiotracers |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | RFA-OD-09-003 |
| Date: | 2009 - 2011 |
| Title: | Fluorescent Boron- and Silicon-Based 18F-Fluoride Captors for the Dual Positron-Emission-Tomography/Fluorescence Imaging of Biomolecules In Vivo |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-PI |
| ID: | DE-PS02-09ER09 |
| Date: | 2009 - 2011 |
| Title: | Standardization of PET/CT quantification (SUV) across different scanner platforms |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | RO1 CA 138495 |
| Date: | 2008 - 2008 |
| Title: | Motion Correction of PET DATA Using Amplitude Gating |
| Funding Source: | GE Medical Solutions |
| Role: | PI |
| ID: | SR2008-00023792EB |
| Date: | 2007 - 2007 |
| Title: | Comparison of image quality between D-ST and D-RX using standard versus Vue Point reconstruction in 2D and 3D modes |
| Funding Source: | GE Healthcare |
| Role: | PI |
| ID: | CS2006-00017040SS |
| Date: | 2006 - 2009 |
| Title: | Whole Body Bone Scanning with SPECT/CT |
| Funding Source: | SIEMENS Medical |
| Role: | PI |
| ID: | SR2007-00018831JW |
| Date: | 2006 - 2007 |
| Title: | PET Image Reconstruction with Motion Compensation |
| Funding Source: | GE Healthcare |
| Role: | PI |
| ID: | CS2006-00017039SS |
| Date: | 2003 - 2005 |
| Title: | Accurate quantification of lung cancer lesion based on PET/CT imaging |
| Funding Source: | Society of Thoracic Radiology |
| Role: | PI |
| Date: | 2003 - 2005 |
| Title: | Radiation Dosimetry of Intra-tumoral Injection of Radionuclides in Human Breast Cancer |
| Funding Source: | N/A |
| Role: | Collaborator |
| ID: | DAMD 17-03-1-0455 |
| Date: | 2003 - 2005 |
| Title: | Accurate quantification of small lung nodules based on PET/CT images |
| Funding Source: | GE Medical Solutions |
| Role: | PI |
| ID: | CS2003-00009880HM |
| Date: | 2003 - 2005 |
| Title: | PET/CT Imaging in the Presence of X-Ray Contrast Enhancing Agents |
| Funding Source: | GE Medical Solutions |
| Role: | PI |
| ID: | LS2003-00009876HM |
| Date: | 2001 - 2006 |
| Title: | NO TITLE PROVIDED |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | R01 CA089198 |
| Title: | From silly and useless to sensible and useful values in quantitative PET imaging |
| Funding Source: | Biotechnology Initiative, King Abdul Aziz City for Science and Technology, SA |
| Role: | Principal Investigator-MDACC |
| Title: | Center of excellence in diagnostic and theragnostic PET/CT (MR) imaging in oncology |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Principal Investigator-MDACC |
| ID: | RFA-R11-MIRA-1 |
Patient Reviews
CV information above last modified June 27, 2025